Introduction {#Sec1}
============

Ptosis refers to either unilateral or bilateral drooping of the upper eyelid, resulting in narrowing of the palpebral fissure and covering part of the eye^[@CR1]--[@CR3]^. Congenital ptosis is present at birth or in the first year of life^[@CR4]^. It is relatively rare compared with other congenital oculopathy. The total prevalence of congenital ptosis in general population is 0.18--1.41%^[@CR5]--[@CR7]^. Despite being mostly a non-progressive disease, congenital ptosis can cause cosmetic, functional and psychosocial problems in children^[@CR8]^. Although most cases of congenital ptosis represent an isolated eyelid malposition, significant ocular associations or consequences are common^[@CR9]^. In addition, it can result in abnormal postures such as backward tilt of the head, chin elevation and even orthopedic problems in some severe cases^[@CR4],[@CR10],[@CR11]^. Most patients with congenital ptosis need surgical correction.

Amblyopia, strabismus and refractive errors have aroused much more attention globally over the past decades. Amblyopia is defined as decreased vision due to abnormal development of visual cortex in infancy or childhood^[@CR12],[@CR13]^. Strabismus, also known as squint, may interfere with normal binocular depth perception and thereby cause substantial physical disturbance^[@CR12]^. Amblyopia and strabismus are common reasons of low vision and are responsible for reduced life qualities of children. Refractive errors are the leading causes of blindness around the world^[@CR14]^. It has been reported that the prevalence of amblyopia, strabismus and refractive errors among patients with congenital ptosis were much higher than those among the general population. Early diagnosis and treatment of congenital ptosis will contribute to prevention and management of these ocular abnormalities.

To the best of our knowledge, the prevalence of amblyopia, strabismus and refractive errors among patients with congenital ptosis vary widely across studies and have not been systemically reviewed. Against this background, we conducted the first systematic review and meta-analysis of eligible observational studies of the prevalence of amblyopia, strabismus and refractive errors in congenital ptosis.

Results {#Sec2}
=======

Summary of included studies {#Sec3}
---------------------------

The detailed steps were given as a PRISMA flowchart (Fig. [1](#Fig1){ref-type="fig"}). A total of 3,633 articles were identified. After removal of duplicates and non-relevant studies, the abstracts of the remaining articles were reviewed. 53 articles with potentially relevant studies were further identified in full. Overall, 24 published studies were considered eligible (Table [1](#Tab1){ref-type="table"}), including 19 studies for amblyopia^[@CR5],[@CR8],[@CR10],[@CR15]--[@CR30]^, 13 for strabismus^[@CR5],[@CR8],[@CR10],[@CR19],[@CR21],[@CR22],[@CR26],[@CR27],[@CR29],[@CR31]--[@CR34]^ and 8 for refractive errors^[@CR8],[@CR10],[@CR21],[@CR24],[@CR26],[@CR27],[@CR29],[@CR35]^. Among the 24 eligible studies, 3 were population-based and 21 were hospital-based. 20 studies reviewed were written in English, 1 in Mandarin, 1 in French, 1 in Germany and 1 in Portuguese. The included studies represented four geographical regions. 10 studies were from America, 8 from Asia, 5 from Europe and 1 from Africa. The sample sizes in the included studies ranged from 36 to 216, with a combined total of 2,589. For more details, refer to Table [1](#Tab1){ref-type="table"}.Figure 1PRISMA flowchart of study selection process.Table 1Characteristics of the included study.StudyDiseaseRegionPublicationStudy DesignSettingMean age (year)Male ratioTime span (year)sampleQualityAnderson RL^[@CR32]^strabismusUSA1980cross-sectional studyhospital-basedNANA31138Anderson RL^[@CR14]^amblyopiaUSA1980cross-sectional studyhospital-basedNANA31238Griepentrog GJ^[@CR15]^amblyopiaUSA2013retrospective studypopulation-based1.31.2940967Griepentrog GJ^[@CR33]^strabismusUSA2014retrospective studypopulation-based1.31.2940967Berry-Brincat A^[@CR5]^amblyopia\
strabismus\
refractive errorsUK2009retrospective studyhospital-based3.911.510155\
155\
1558Dray JP^[@CR16]^amblyopiaFrance2002retrospective studyhospital-basedNANA121306Gautam P^[@CR17]^amblyopiaNepal2016retrospective studyhospital-based23NA21704Júnior G^[@CR34]^strabismusBrasil2011cross-sectional studyhospital-based7.2210424Harrad RA^[@CR18]^amblyopia\
strabismusUK1988retrospective studyhospital-basedNANA5216\
2164Hornblass A^[@CR19]^amblyopiaUSA1995retrospective studyhospital-basedNANA14367Ho YF^[@CR35]^strabismusTaiwan2017retrospective studyhospital-based3.861.8103197Merriam WW^[@CR20]^amblyopia\
strabismus\
refractive errorsUSA1980retrospective studyhospital-basedNANA365\
65\
658Skaat A^[@CR21]^amblyopia\
strabismusIsrael2013retrospective studyhospital-based0.831.3111162\
1626Srinagesh V^[@CR22]^amblyopia\
strabismus\
refractive errorsUSA2011retrospective studyhospital-based2.5NA492\
87\
877Handor H^[@CR23]^amblyopiaMorocco2014retrospective studyhospital-based101.757446Huo L^[@CR24]^amblyopia\
refractive errorsChina2012retrospective studyhospital-based16.83NA1285\
857Abolfazl K^[@CR25]^amblyopiaIran2010cross-sectional studyhospital-basedNA1.5621007Lin LK^[@CR26]^amblyopia\
strabismus\
refractive errorsUSA2008retrospective studyhospital-basedNA1.777130\
130\
1306Stark N^[@CR27]^amblyopia\
strabismus\
refractive errorsGerman1984retrospective studyhospital-basedNANA654\
54\
545Stein A^[@CR28]^amblyopiaUSA2014retrospective studyhospital-based1.54NA18847Thapa R^[@CR29]^amblyopia\
strabismus\
refractive errorsNepal2010cross-sectional studyhospital-based16NA178\
78\
788Hashemi H^[@CR30]^amblyopia\
strabismusIran2015cross-sectional studypopulation-based71.41158\
589Rong H^[@CR31]^amblyopiaChina2016retrospective studyhospital-based7.4NA21878Yalaz M^[@CR36]^refractive errorsTurkey1996retrospective studyhospital-based15.751.555394NA, Not Available.

Quality assessment {#Sec4}
------------------

All of the selected articles were scored and listed in Table [1](#Tab1){ref-type="table"}. The details could be found in Supplementary Table [S1](#MOESM1){ref-type="media"}. Of all the articles included, 7 were of high quality and 17 were of moderate quality. There were no articles with low quality rating.

Prevalence of amblyopia in congenital ptosis {#Sec5}
--------------------------------------------

The prevalence of amblyopia extracted from each study ranged from 4.7% to 50.0% (Fig. [2](#Fig2){ref-type="fig"}); heterogeneity was substantial (χ² = 103.89, p \< 0.01; I² = 82.7%). As a result, a random effects model was used. The overall pooled prevalence of 19 studies was 22.7% (95%CI 18.5--27.8%). The sensitivity analysis showed that the result was not excessively influenced by any one study. Publication bias was examined through the use of a funnel plot (Supplementary Fig. [S1a](#MOESM1){ref-type="media"}), and the asymmetry was further tested by using an Egger's test (p = 0.001) and a Begg's test (p = 0.01). The outcomes indicated that there had a risk of publication bias, so we used the trim and fill method to recalculate the pooled prevalence (Supplementary Fig. [S1b](#MOESM1){ref-type="media"}). This analysis did not change the result, suggesting that it was not affected by publication bias. The prevalence was further analyzed by subgroups (year of publication, study design, setting, sample size, time span, region and the quality of study). Although results were inconsistent, the prevalence of amblyopia in congenital ptosis did not differ substantially in all the subgroups we made (Table [2](#Tab2){ref-type="table"}). It suggested that these grouping variables could not explain the high between-study heterogeneity in the prevalence estimates. Further analyses by meta-regression also showed that none of the factors we explored were significantly associated with heterogeneity (Table [3](#Tab3){ref-type="table"}).Figure 2Pooled prevalence of amblyopia in congenital ptosis.Table 2Subgroup analyses for prevalence of amblyopia and strabismus in congenital ptosis.SubgroupNumber of studiesEstimated prevalence (%; 95% CI)I^2^ (%)**Amblyopia**Year of publicationBefore 200050.227 (0.133, 0.386)88.22000--200930.240 (0.201, 0.287)0.0After 2009110.219 (0.163, 0.295)84.9RegionAmerica70.198 (0.167, 0.235)0.0Europe40.270 (0.172, 0.424)89.6Asia70.228 (0.155, 0.338)88.9Africa10.250 (0.142, 0.440)NAStudy designCross-sectional study40.298 (0.195, 0.455)84.6Retrospective study150.210 (0.167, 0.263)81.1Settinghospital-based170.222 (0.181, 0.272)80.1population-based20.271 (0.084, 0.876)93.6Sample size (patients) \< 100100.237 (0.170, 0.331)82.3 ≥ 10090.217 (0.167, 0.281)83.6Time span (years) \< 10120.247 (0.188, 0.323)86.1 ≥ 1070.201 (0.168, 0.241)24.2Quality4--7 (moderate quality)130.208 (0.159, 0.272)82.88--11 (high quality)60.270 (0.199, 0.366)80.8**Total**190.227 (0.185, 0.278)82.7**Strabismus**Year of publicationBefore 200040.240 (0.177, 0.325)61.82000--200920.151 (0.113, 0.202)0.0After 200970.186 (0.150, 0.231)41.9RegionAmerica60.182 (0.127, 0.261)68.3Europe30.195 (0.140, 0.270)56.4Asia40.203 (0.155, 0.266)56.0Study designCross-sectional study40.270 (0.209, 0.349)28.5Retrospective study90.177 (0.155, 0.201)6.0Settinghospital-based110.200 (0.165, 0.242)62.3population-based20.162 (0.109, 0.241)0.0Sample size (patients)\<10070.198 (0.150, 0.261)44.5≥10060.193 (0.153, 0.244)70.1Time span (years)\<1080.214 (0.167, 0.273)62.2≥1050.170 (0.144, 0.200)0.0Quality4--7 (moderate quality)80.182 (0.159, 0.208)3.58--11 (high quality)50.217 (0.152, 0.310)71.4**Total**130.196 (0.165, 0.232)56.9Table 3Meta-regression analyses for prevalence of amblyopia and strabismus in congenital ptosis.Meta-regression coefficient (%)95%CIp**Amblyopia**Year of publication, continuous−0.002(−0.021, 0.018)0.839Region (Asia vs others)0.049(−0.446, 0.544)0.836Study design0.353(−0.186, 0.891)0.185Setting0.262(−0.497, 1.021)0.476Sample size, continuous−0.003(−0.007, 0.002)0.213Time span, continuous−0.016(−0.043, 0.011)0.221Quality, continuous0.127(−0.041, 0.294)0.130**Strabismus**Year of publication, continuous−0.011(−0.023, 0.001)0.061Region (Asia vs others)0.065(−0.361, 0.491)0.744Study design0.467(0.183, 0.751)0.004Setting−0.205(−0.815, 0.404)0.474Sample size, continuous−0.001(−0.003, 0.001)0.388Time span, continuous−0.012(−0.032, 0.008)0.231Quality, continuous0.004(−0.131, 0.139)0.947

Prevalence of strabismus in congenital ptosis {#Sec6}
---------------------------------------------

Estimates of the prevalence of strabismus ranged from 10.3% to 31.9% (Fig. [3](#Fig3){ref-type="fig"}); heterogeneity was pronounced (χ² = 27.86, p \< 0.01; I² = 56.9%). The random effects pooled prevalence was 19.6% (95%CI 16.5--23.2%). In the sensitivity analysis, we failed to attribute the heterogeneity to any single study. Publication bias was assessed by constructing a funnel plot (Supplementary Fig. [S2](#MOESM1){ref-type="media"}) followed by an Egger's test (p = 0.288) and a Begg's test (p = 0.583), which indicated an insignificant level of publication bias. The results of stratified meta-analyses in subgroups were shown as below (Table [2](#Tab2){ref-type="table"}). Prevalence for the subgroup of cross-sectional studies (27.0%, I^2^ = 28.5%) was higher than that of retrospective studies (17.7%, I^2^ = 6.0%), and there was a significant difference (95%CI 20.9--34.9% vs. 95%CI 15.5--20.1%; p \< 0.01). None of other covariates were remarkable. In meta-regression analyses, we found that the study design (p = 0.004) and the year of publication (p = 0.061) were two important causes for the between-study heterogeneity (Table [3](#Tab3){ref-type="table"}).Figure 3Pooled prevalence of strabismus in congenital ptosis.

Prevalence of refractive errors in congenital ptosis {#Sec7}
----------------------------------------------------

There were eight studies reporting the prevalence of refractive errors in congenital ptosis. Among them, 3 focused on the prevalence of myopia^[@CR24],[@CR29],[@CR35]^, 3 on hyperopia^[@CR24],[@CR29],[@CR35]^, 4 on astigmatism^[@CR8],[@CR24],[@CR27],[@CR29]^ and 6 on anisometropia^[@CR8],[@CR10],[@CR21],[@CR24],[@CR26],[@CR27]^. The variance-stabilising double arcsine transformation was implemented previously to calculate the prevalence of myopia and hyperopia in congenital ptosis. We did not perform funnel plots, Egger's tests, Begg's tests, subgroup analyses and meta-regression analyses for a lack of data in this part. The prevalence of myopia ranged from 3.8% to 55.3% (Fig. [4](#Fig4){ref-type="fig"}). There was a high level of heterogeneity (χ² = 67.87, p \< 0.01; I² = 97.1%) and then a random effects model was conducted. The pooled prevalence was 30.2% (95%CI 3.0--69.8%). The prevalence of hyperopia ranged from 2.4% to 5.1% and with no evidence of heterogeneity (χ² = 0.76, p \> 0.1; I² = 0.0) (Fig. [4](#Fig4){ref-type="fig"}). A fixed effects model was conducted and the overall pooled prevalence was 4.0% (95%CI 1.8--7.1%). The prevalence of astigmatism ranged from 9.0% to 77.8% (Fig. [4](#Fig4){ref-type="fig"}). The overall pooled prevalence was 22.2% (95%CI 7.8--63.1%) using a random effects model (χ² = 94.58, p \< 0.01; I² = 96. 8%). Sensitivity analysis reported that no individual study affected the stability of the prevalence. The prevalence of anisometropia ranged from 12.3% to 55.6% with a pooled prevalence of 20.8% (95%CI 11.9--36.5%) using a random effects model (χ² = 57.09, p \< 0.01; I² = 91.2%) (Fig. [4](#Fig4){ref-type="fig"}). Sensitivity analysis showed that the study of Stark N *et al*.^[@CR27]^ substantially influenced the pooled prevalence. The prevalence was 17.3% (95%CI 13.1--22.9%) and the heterogeneity decreased to 44.5% after excluding this study.Figure 4Pooled prevalence of refractive errors in congenital ptosis.

Discussion {#Sec8}
==========

This systematic review and meta-analysis of 24 studies involving 2,589 individuals demonstrated the prevalence of amblyopia, strabismus and refractive errors in congenital ptosis. The quality of all the included studies was acceptable. The highest prevalence was revealed for myopia with 30.2% (95%CI 3.0--69.8%), followed by 22.7% (95%CI 18.5--27.8%) for amblyopia, 22.2% (95%CI 7.8--63.1%) for astigmatism, 19.6% (95%CI 16.5--23.2%) for strabismus, 17.3% (95%CI 13.1--22.9%) for anisometropia, and 4.0% for hyperopia (95%CI 1.8--7.1%). It was better to consider the confidence intervals rather than the pooled results for the high heterogeneity.

Congenital ptosis is clearly related with amblyopia and always with coexistent strabismus or anisometropia^[@CR10]^. Young children have often lost the best opportunity for treatment when diagnosed, which leads to a high rate of complications. The main implication of our study is that early examination and follow up of patients with congenital ptosis to monitor their visual development is necessary.

Amblyopia is one of the most common reasons for decreased vision among patients with congenital ptosis^[@CR16]^. It has an estimated prevalence of 3.0% to 3.2% in the general population^[@CR15],[@CR17]^. The rate among patients with congenital ptosis has been reported to be higher. In our study, the pooled prevalence of amblyopia in congenital ptosis was estimated as 22.7% (95%CI 18.5--27.8%), at an approximately 7 times greater than that in the general population. There is no definitive explanation of why the prevalence of amblyopia is higher among patients with congenital ptosis. Most authors deemed that the leading causes of amblyopia in congenital ptosis were the coexistent strabismus or significant refractive error^[@CR10],[@CR17],[@CR19],[@CR26]^. Griepentrog GJ *et al*.^[@CR16]^ found that eyelid occlusion of the visual axis was the main cause. Early surgery of congenital ptosis has been proved to be effective for prevention and elimination of amblyopia.

Of the 19 studies for amblyopia, a large amount of heterogeneity was identified. Sensitivity analysis showed that our results were not materially different. And there was no evidence of publication bias after applying the trim and fill method. To explore the cause of heterogeneity, subgroup analyses and meta-regression analyses were conducted. However, these analyses did not provide a clear explanation. Characteristics that we could not test might have contributed to heterogeneity, such as age, laterality, comorbidity, ptosis severity, etc.

Strabismus has an estimated prevalence of 1--5% in the general population^[@CR17]^. The pooled prevalence showed that 19.6% (95%CI 16.5--23.2%) of patients with congenital ptosis suffered from strabismus, suggesting that strabismus was at least 4 times more common than that in the general population. However, it is still controversial on the precise cause for the remarkable higher prevalence of strabismus in congenital ptosis. The traditional view is that the strabismus may occur secondary to the disruption of binocularity resulting from the visual occlusion by the ptotic eyelid^[@CR31],[@CR36]^. Other hypotheses center around a genetic predisposition or an intrauterine insult to the overlapping regions of the oculomotor nuclear complex or the third cranial nerve^[@CR17],[@CR37]^.

Of the 13 studies for strabismus, considerable heterogeneity was found. Sensitivity analysis did not reveal significant differences. No evidence for publication bias was observed. We have found that the study design and the year of publication were two important causes for heterogeneity in our subgroup analyses and meta-regression analyses. Regarding study design, cross-sectional studies showed higher prevalence than retrospective studies did. One of the possible causes could be that some patients with strabismus were excluded for their incomplete or missed data when evaluated in retrospective studies. Further, some retrospective studies did not concern history of ptosis surgery or previous treatment for strabismus, which might result in an underestimation of the true prevalence. Older studies showed significantly higher prevalence than newer studies did. This changing trend may be due to the more attention paid to ptosis which used to be regarded as a cosmetic problem and the more effective surgical treatments used nowadays. Unknown confounding factors could still exist and thus influenced the pooled analysis.

Until now, studies on refractive errors in congenital ptosis are rare. In this study, the pooled prevalence of myopia was 30.2% (95%CI 3.0--69.8%), astigmatism 22.2% (95%CI 7.8--63.1%), anisometropia 17.3% (95%CI 13.1--22.9%) and hyperopia 4.0% (95%CI 1.8--7.1%), respectively. The proportion of different types of refractive errors in congenital ptosis varied between studies^[@CR8],[@CR38]^. Gusek-Schneider *et al*.^[@CR39]^ found that children with isolated congenital ptosis had more spherical and cylindrical diopters than control group. Yalaz M *et al*.^[@CR35]^ proposed that in simple congenital ptosis the development of myopia and anisometropia might be due to the narrow palpebral aperture. Some studies suggested that the development of astigmatism in congenital ptosis was presumably due to eyelid tension and changes in the corneal curvature^[@CR5],[@CR25],[@CR40],[@CR41]^. Ji-Sun P *et al*.^[@CR42]^ recommended frequent refraction tests to ensure that the best spectacle-corrected visual acuity was obtained. And what cannot be ignored is that some refractive errors are not apparent at presentation. In this case, close follow-up is necessary, not just for refractive changes but also for other abnormalities which may progress, including latent amblyopia and strabismus.

There were 8 studies for refractive errors. Significant heterogeneity was observed in most estimates except in hyperopia. For myopia, the difference between studies might be associated with the various ethnicities and age groups of patients. It has been reported that the prevalence of myopia in East Asian countries such as China is much higher^[@CR43],[@CR44]^. Huo L *et al*.^[@CR24]^ deemed that long-standing congenital ptosis might produce myopia. For hyperopia, the result was robust. For astigmatism, sensitivity analysis showed that the effects of bias were not important. Kame RT *et al*.^[@CR45]^ suggested that the greater tightness and narrower palpebral apertures of the Asian eyelids might lead to the greater rates of astigmatism. Besides, infants exhibited a high incidence of corneal astigmatism,and the cornea flattened with significantly reduced astigmatism as children grew older^[@CR46]^. These could be potential confounding factors for the estimation. For anisometropia, sensitivity analysis showed that the study of Stark N *et al*.^[@CR27]^ contributed to most of the observed heterogeneity. Limitations of this study included an imprecise definition of anisometropia and a small sample size, which might have yielded more extreme prevalence estimates.

This review has a few limitations. First, as in other meta-analyses of prevalence, substantial heterogeneity was observed^[@CR47],[@CR48]^. Although we attempted to find the causes of it by conducting subgroup analyses and meta-regression analyses, the between-study heterogeneity could not be fully explained by the variables we examined. We suspect that other factors such as sex, age, laterality, comorbidity, ptosis severity, previous treatment etc. may also influence the prevalence. Therefore, the results of this meta-analysis should be prudently considered. Second, most of the available studies for our meta-analysis were hospital-based ones with limited sample sizes. Those hospitalized patients might present with more severe ptosis or other ophthalmic diseases, so the true prevalence might be higher still. Third, retrospective medical records were used in some studies. These data were taken from different ophthalmologists and the recorded information might be limited. Fourth, the definitions of amblyopia, strabismus and refractive errors were various. Actually, a detailed description of the diagnostic method was lacking in some reviewed studies. Fifth, as we did not consult unpublished articles, publication bias could not be excluded. Despite all of these limitations, it might be the first systematic review and meta-analysis to assess the prevalence of amblyopia, strabismus and refractive errors in congenital ptosis.

In conclusion, the prevalence of amblyopia, strabismus and refractive errors in congenital ptosis are much higher than those in the general population. These complications may be minimized or avoided with early surgical correction. This study highlights the importance of early assessment and timely treatment of patients with congenital ptosis. Moreover, a large-scale, multicenter-based prospective study using standard diagnostic methods and screening tools is recommended, and it will provide a more accurate estimate of the prevalence of amblyopia, strabismus and refractive errors in congenital ptosis.

Methods {#Sec9}
=======

Literature search {#Sec10}
-----------------

We preformed this systematic review and meta-analysis following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement^[@CR49]^. We systematically searched all publications using Cochrane, Pubmed, Medline, Embase and Web of Science up to July 2017. We included a combination of search terms, such as Strabismus/Squint, Amblyopia/weak sight, Refractive Errors/ametropia, ptosis/blepharoptosis, etc. For the detailed search, please refer to Supplementary Appendix A. No restrictions were imposed based on language or year of publication. We also manually scrutinized the reference lists of all included studies. Titles and abstracts of studies were initially reviewed to exclude unrelated ones. Then the remaining articles were evaluated in full. All the relevant studies were independently scanned by two reviewers (YW and YX). When discrepancies occurred, consensus was achieved by consulting the senior author (JY).

Study selection {#Sec11}
---------------

We included studies that met the following criteria: (1) a full-text article could be obtained; (2) a cross-sectional study, case-control study, cohort study or randomized control trial; (3) the diagnosis was based on objective examination or medical records of qualified pediatricians or ophthalmologists; (4) the studies differentiated congenital ptosis from other kinds of ptosis; (5) the studies provided the extractable data of the number of patients had amblyopia, strabismus or refractive errors with congenital ptosis. Case reports, letters to the editor, drug trials, reviews or any other studies without raw or sufficient data were excluded. We chose the study with the most complete data if populations overlapped between them. All the studies were independently selected by two reviewers (YW and YX) on the basis of criteria. Disagreements between the two reviewers were resolved and adjudicated by the senior author (JY).

Data extraction {#Sec12}
---------------

These following characteristics were independently extracted by two reviewers (YW and XL): name of the first author, region of the study population, year of publication, study design, setting, mean age, male ratio, time span, the number of patients in the studies and the number of patients had amblyopia, strabismus or refractive errors with congenital ptosis.

Quality assessment {#Sec13}
------------------

The methodological quality was assessed using the checklist recommended by Agency for Healthcare Research and Quality (AHRQ)^[@CR50]^. The system allowed a total score of up to 11 points. If an item was answered 'NO' or 'UNCLEAR', it was scored '0'; if the answer was 'YES', then scored '1'. Studies would be classified into three grades according to their scores: low quality (0--3 points), moderate quality (4--7 points) and high quality (8--11 points).

Statistical analysis {#Sec14}
--------------------

We used the STATA (Version 12.0, Stata corporation, College Station, Texas, USA) for proportion and summary meta-analysis. Statistical tests were two-sided and used a significant threshold of p \< 0.05. The prevalence of amblyopia, strabismus and refractive errors in congenital ptosis were combined to pooled prevalence respectively, and 95% confidence intervals (CIs) were calculated. They were converted into natural logarithms in advance. For data with extremely low prevalence, we handled them by the variance-stabilising double arcsine transformation previously^[@CR51]^.

Heterogeneity was estimated using Cochran's Q (reported as χ² and p values) and I^2^ statistics. P values less than 0.1 and/or I^2^ greater than 50% were considered to be high degrees of between-study heterogeneity and then a random effects model was used; otherwise, a fixed effects model was used^[@CR52]^. Sensitivity analysis was performed to assess the stability of the results by sequentially omitting one study each time. Reanalyzing the remaining studies was followed. Publication bias was assessed by the funnel plot, Egger's test and Begg's test for sections with 10 or more studies. If publication bias was indicated, we further conducted a trim and fill analysis to evaluate the number of missing studies. Potential sources of heterogeneity were further investigated using subgroup analyses and meta-regression analyses when at least 10 studies were available. The grouping variables were as follows: year of publication (before 2000, 2000--2009 or after 2009), study design (retrospective or cross-sectional), setting (hospital-based or population-based), sample size (less or more than 100), time span (less or more than 10 years), region (different continents) and the quality of study (low, moderate or high). Meta-regression analyses were developed with the same covariates. Other grouping variables were limited by the available data.
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